Rare diseases
Investigational molecules
Locations
Back to Czechia24 clinical trials in Horovice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
CzechiaStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
CzechiaCzechiaStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
CzechiaStudy on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients
CzechiaStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
CzechiaStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency
CzechiaStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
CzechiaStudy Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer
CzechiaStudy of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hormone receptor-positive breast cancer treatments, including studies of novel therapies for both early-stage and advanced disease.
Multiple studies evaluating new therapeutic combinations to improve patient outcomes and reduce recurrence rates.
Research focusing on inflammatory bowel conditions and colorectal cancer, with emphasis on developing targeted treatments for various stages of disease.
Comprehensive evaluation of new therapeutic approaches for both inflammatory and oncological conditions.
Advanced research into non-small cell lung cancer treatments, particularly focusing on targeted therapies and immunotherapy combinations.
Investigating breakthrough treatments for specific genetic mutations in lung cancer.
Clinical trials examining new approaches for metastatic prostate cancer, including hormone-sensitive and castration-resistant cases.
Evaluating novel therapeutic combinations to improve survival rates and treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
